article · Cureus
An analysis of global health databases examined biomedical research funding patterns and gender disparities in Tanzania. Across 438 projects led by 324 unique principal investigators, a total of 218,409,329 US dollars was allocated. Most funding supported collaborative projects rather than direct awards, with the European and Developing Countries Clinical Trials Partnership providing over 75 percent of the total. Funding peaked in 2020 and 2022, and the National Institute for Medical Research secured the largest institutional share at nearly 44 percent. Male investigators accounted for over 70 percent of leadership roles and received more than double the funding awarded to female investigators overall. However, this pattern reversed in 2023, when female principal investigators secured more funding than their male peers. Overall, research capital remains concentrated within a small number of organisations and funding bodies.
Understanding funding flows helps research leaders and policymakers design fairer systems. While biomedical investment in Tanzania has grown, heavy reliance on a single funder and a few institutions creates systemic vulnerability. Tracking persistent gender imbalances among project leaders highlights the need for sustained policies that support equitable access to research grants and career progression for female scientists.
The abstract does not indicate an application pathway or commercialisation opportunity, as it focuses on funding distribution and policy analysis.
AI-generated from the published abstract. Always read the original work before citing.
Background Research funding is crucial for advancing scientific knowledge and innovation. Understanding patterns and trends in research funding, including potential gender disparities, can provide valuable insights for policymakers, funding agencies, and researchers. This study aimed to analyze the distribution of research funding in Tanzania, identify major contributors, uncover trends over the past years, and examine gender disparities among principal investigators (PIs). Methods Data from the National Institutes of Health (NIH) funding database and World RePORT were utilized. Data cleaning and preprocessing ensured consistency and accuracy, with funding amounts converted to common currency (USD) for analysis. Statistical and trend analyses were performed to identify key patterns, focusing on funding distribution by research organization, funding organization, fiscal year, type of record, and PI gender. Results A total of $218,409,329 were distributed across 438 projects led by 324 unique PIs. Male PIs accounted for 228 (70.4%), females for 91 (28.1%), and five (1.5%) were of unspecified gender. Collaborative projects comprised 374 entries ($158,121,528.60), and direct funding accounted for 64 projects ($60,287,799.96). The European and Developing Countries Clinical Trials Partnership contributed the most ($165,598,586; 75.8%), followed by the Wellcome Trust ($12,282,858; 5.6%) and the European Commission ($12,017,629; 5.5%). Funding rose steadily, peaking in 2020 and 2022 at over US $40 million. The National Institute for Medical Research received the highest total cost (US$95,453,357; 43.7%). Male PIs led more projects and received $49,038,802, compared to $22,475,127 for female PIs. In 2023, however, female PIs received more funding ($5,517,171) than male PIs ($4,354,089), reversing previous trends. Conclusions Research funding in Tanzania remains concentrated among a few institutions and is dominated by one major donor. Although overall funding has increased, significant gender disparities persist. The 2023 shift toward greater female PI funding is promising but requires sustained policy attention. These insights can inform equitable research and investment strategies for Tanzania.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.7759/cureus.94912
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
